Hims & Hers Health is trading at €25.28, down 4.53%, with no fresh company-specific announcement clearly explaining the August 28, 2026 decline.
- Investors may still be monitoring reported Visa payment-dispute concerns in the weight-loss subscription business, which previously pressured shares on August 24.
- The broader market is modestly positive, so market-wide weakness does not explain today’s drop.
- Recent earnings and guidance news dates to August 10.